Form 4: Zynex Inc. COO Anna Lucsok Reports Stock Award and Tax Withholding

Anna Lucsok, Chief Operating Officer of Zynex Inc., reports the acquisition of restricted stock and shares withheld for tax obligations.

Summary

• On April 27, 2025, Anna Lucsok, the Chief Operating Officer of Zynex Inc., was granted a restricted stock award of 7,500 shares.
• These shares vest equally over four years, starting one year from the grant date, according to the company's 2017 Stock Incentive Plan.
• On April 28, 2025, 2,716 shares were withheld by Zynex Inc. to cover income tax obligations related to the settlement of Restricted Stock Awards.
• Following these transactions, Lucsok directly owns 38,330 shares of common stock and 63,535 shares of restricted stock awards that have not vested.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to executive compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The grant of restricted stock aligns the COO's interests with those of the shareholders, incentivizing long-term performance.

Industry Context

Stock awards are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock awards are a typical component of executive compensation packages in the medical device industry, similar to companies like Medtronic, Stryker, and Boston Scientific.
• The vesting schedule of four years is also standard practice to ensure long-term commitment from the executive.

Stakeholder Impact

• The stock award incentivizes the COO to improve company performance, potentially benefiting shareholders.
• The tax withholding ensures compliance with tax regulations.

Key Dates

Keywords

Zynex Inc., Anna Lucsok, Chief Operating Officer, restricted stock award, Form 4, stock incentive plan, tax withholding, ZYXI